Priovant Therapeutics, Inc.

This study tests an oral medication called brepocitinib in adults with active uveitis, a type of eye inflammation that can cause vision loss. The goal is to see if the drug can control the disease and prevent flare-ups better than a placebo. About 371 participants will take the p…

This study tests an oral medication called brepocitinib in 241 adults with dermatomyositis, a rare disease causing muscle weakness and skin rashes. The drug aims to reduce disease activity over 52 weeks. Participants are randomly assigned to receive one of two doses or a placebo,…